Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 1/20 | 0.51 |
| ▸ | CTSS | P25774 | 13/20 | 0.49 |
| ▸ | CTSK | P43235 | 11/20 | 0.49 |
| ▸ | CTSB | P07858 | 3/20 | 0.47 |
| ▸ | CTSL | P07711 | 3/20 | 0.47 |
| ▸ | KDM4A | O75164 | 1/20 | 0.47 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.42 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30159605 | 0.88 | KCNA5 (0.56) | KCNA5CTSSCTSKKDM4AMALT1 | |
| SCHEMBL8018113 | 0.88 | KCNA5 (0.56) | KCNA5CTSSCTSKKDM4AMALT1 | |
| SCHEMBL5855817 | 0.83 | KCNA5 (0.48) | KCNA5CTSSCTSKCTSBCTSL | |
| SCHEMBL30454240 | 0.82 | KCNA5 (0.52) | KCNA5CTSSCTSKKDM4AMALT1 | |
| SCHEMBL6874894 | 0.82 | KCNA5 (0.52) | KCNA5CTSSCTSKKDM4AMALT1 | |
| SCHEMBL21960819 | 0.81 | KCNA5 (0.56) | KCNA5CTSSCTSKCTSBCTSL | |
| SCHEMBL6924987 | 0.81 | KCNA5 (0.51) | KCNA5KDM4AMALT1NAMPTHDAC10 | |
| SCHEMBL7654695 | 0.81 | KCNA5 (0.54) | KCNA5CTSSCTSKKDM4AMALT1 | |
| SCHEMBL825511 | 0.79 | KCNA5 (0.53) | KCNA5CTSSCTSKKDM4ANAMPT | |
| SCHEMBL8240426 | 0.79 | KCNA5 (0.50) | KCNA5CTSSCTSKKDM4AMALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050250765-A1 | Diazepinones as antiviral agents | CHO HIDETSURA | 2005-11-10 | — | — | US | disclosed |
| WO-2002014324-A2 | DIAZEPINONES AS ANTIVIRAL AGENTS | WARNER-LAMBERT COMPANY (US) | 2002-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050250765-A1 | Diazepinones as antiviral agents | ZC3HAV1, ECI1, ZC3HAV1L | KCNA5 2016/4885CTSS 2164/4885CTSK 2200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.